98 related articles for article (PubMed ID: 15840125)
1. Weekly low-dose docetaxel in the treatment of lung metastases from angiosarcoma of the head.
Yamada M; Hatta N; Mizuno M; Oishi N; Takehara K
Br J Dermatol; 2005 Apr; 152(4):811-2. PubMed ID: 15840125
[No Abstract] [Full Text] [Related]
2. Complete long-term response of angiosarcoma of the scalp with cervical lymph node metastases treated with a combination of weekly and monthly docetaxel.
Nakamura Y; Nakamura Y; Hori E; Furuta J; Kawachi Y; Otsuka F
Br J Dermatol; 2010 Dec; 163(6):1357-8. PubMed ID: 20731655
[No Abstract] [Full Text] [Related]
3. Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Hitt R; Amador ML; Quintela-Fandino M; Jimeno A; del Val O; Hernando S; Cortes-Funes H
Cancer; 2006 Jan; 106(1):106-11. PubMed ID: 16329139
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel.
Isogai R; Kawada A; Aragane Y; Tezuka T
J Dermatol; 2004 Apr; 31(4):335-41. PubMed ID: 15187330
[TBL] [Abstract][Full Text] [Related]
5. Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.
Schuette W; Nagel S; Blankenburg T; Lautenschlaeger C; Hans K; Schmidt EW; Dittrich I; Schweisfurth H; von Weikersthal LF; Raghavachar A; Reissig A; Serke M
J Clin Oncol; 2005 Nov; 23(33):8389-95. PubMed ID: 16293869
[TBL] [Abstract][Full Text] [Related]
6. Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancer.
Lai CL; Tsai CM; Chiu CH; Wang GS; Su WJ; Chen YM; Perng RP
Jpn J Clin Oncol; 2005 Dec; 35(12):700-6. PubMed ID: 16303792
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel administration schedule: from fever to tears? A review of randomised studies.
Engels FK; Verweij J
Eur J Cancer; 2005 May; 41(8):1117-26. PubMed ID: 15911234
[TBL] [Abstract][Full Text] [Related]
9. Congenital angiosarcoma with transient response to paclitaxel.
Good AB; Nascimento A; Welker KM; Arndt CA
J Pediatr Hematol Oncol; 2008 Jun; 30(6):451-3. PubMed ID: 18525462
[TBL] [Abstract][Full Text] [Related]
10. [Angiosarcoma of the head and neck treated with bevacizumab and paclitaxel].
Becquart O; Girard C; Lesage C; Guillot B
Ann Dermatol Venereol; 2018; 145(6-7):451-453. PubMed ID: 29703639
[No Abstract] [Full Text] [Related]
11. Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Specenier P; Rasschaert M; Vroman P; Van den Brande J; Dyck J; Schrijvers D; Huizing MT; Vermorken JB
Am J Clin Oncol; 2011 Oct; 34(5):472-7. PubMed ID: 20938321
[TBL] [Abstract][Full Text] [Related]
12. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review.
Engels FK; Sparreboom A; Mathot RA; Verweij J
Br J Cancer; 2005 Jul; 93(2):173-7. PubMed ID: 16012521
[TBL] [Abstract][Full Text] [Related]
13. [A case of angiosarcoma of pelvis with pulmonary metastases which responded to paclitaxel].
Tada Y; Takiguchi Y; Terada J; Yoshida T; Shinozaki A; Sakao S; Kasahara Y; Kurosu K; Tanabe N; Tatsumi K; Hiroshima K; Kuriyama T
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2275-7. PubMed ID: 18079629
[TBL] [Abstract][Full Text] [Related]
14. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
Kovács AF; Mose S; Böttcher HD; Bitter K
Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
[TBL] [Abstract][Full Text] [Related]
15. [A case of pulmonary metastases from laryngeal cancer showing a complete response to chemotherapy with docetaxel].
Maeda Y; Fujishiro Y; Chihara Y; Kawanabe W; Fukaya T
Gan To Kagaku Ryoho; 2004 Jan; 31(1):75-7. PubMed ID: 14750325
[TBL] [Abstract][Full Text] [Related]
16. Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: a phase I/II study with 5 years' follow-up.
Brunsvig PF; Hatlevoll R; Berg R; Lauvvang G; Owre K; Wang M; Aamdal S
Lung Cancer; 2005 Oct; 50(1):97-105. PubMed ID: 16005105
[TBL] [Abstract][Full Text] [Related]
17. Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
Bria E; Cuppone F; Ciccarese M; Nisticò C; Facciolo F; Milella M; Izzo F; Terzoli E; Cognetti F; Giannarelli D
Cancer Treat Rev; 2006 Dec; 32(8):583-7. PubMed ID: 16919884
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of angiosarcoma on the nose by combination treatment with electron beam irradiation, recombinant interleukin-2 and docetaxel.
Asano Y; Makino T; Furuichi M; Norisugi O; Shimizu T
Clin Exp Dermatol; 2009 Oct; 34(7):e227-8. PubMed ID: 19302586
[No Abstract] [Full Text] [Related]
19. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel administered every two weeks as second-line chemotherapy for advanced non-small cell lung cancer: a phase II study.
De Petris L; Migliorino MR; Ceribelli A; Martelli O; Di Molfetta M; Mancuso A; De Santis S; Di Salvia R; De Marinis F
Anticancer Res; 2005; 25(6C):4713-7. PubMed ID: 16334165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
